Pelvic floor disorders in postpartum adolescents in the Western Amazon: a cross-sectional study

Imagem de Miniatura
Arquivos
art_ZUCHELO_Pelvic_floor_disorders_in_postpartum_adolescents_in_the_2018.PDF (598.83 KB)
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2018
Editora
DOVE MEDICAL PRESS LTD
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
ZUCHELO, Lea Tami Suzuki
SANTOS, Edige Felipe de Sousa
FIGUEIREDO, Francisco Winter Dos Santos
ADAMI, Fernando
BEZERRA, Italla Maria Pinheiro
RAIMUNDO, Rodrigo Daminello
ABREU, Luiz Carlos de
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF WOMENS HEALTH, v.10, p.477-486, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: To analyze the postpartum pelvic floor disorders (PFD) and mode of delivery among adolescents, late adolescents, and young women from Western Amazon. Patients and methods: Cross-sectional study was carried out in the urban area of Western Amazon in the city of Rio Branco, Acre, Brazil, from October 2016 to February 2017. This is a convenience sample of women up to 30 years who completed six months postpartum, separated in three groups according to maternal age: adolescents (age <= 19 years), late adolescents (20-24 years), and young women (25-30 years). Participants were home interviewed and answered Pelvic Floor Distress Inventory-20 (PFDI-20). Delivery clinical data were collected from patient's medical records. Results: In total, 285 participants were interviewed: 41 adolescents, 103 late adolescents, and 141 young women. After controlling for confounding factors, prevalences of PFD were higher in the adolescents' group compared with the young women's group (urinary incontinence [UI], prevalence ratio [PR] = 1.75, 95% CI 1.14-2.69; urge urinary incontinence [UUI], PR = 1.88, 95% CI 1.02-3.47; stress urinary incontinence, PR = 2.00, 95% CI 1.11-3.62; fecal incontinence [FI], PR = 4.40, 95% CI 1.36-14.27). PFDI-20 scores also presented higher values in the adolescent group (Pelvic Organ Prolapse Distress Inventory [POPDI], PR = 2.02, 95% CI 1.49-2.75; urinary distress inventory [UDI], PR = 2.09, 95% CI 1.47-2.98; PFDI, PR = 2.12, 95% CI 1.47-2.98). Analyzing the influence of cesarean section, adolescents have higher prevalence of UI (PR = 1.84, 95% CI 1.04-3.26, P=0.037), UUI (PR = 2.36, 95% CI 1.03-5.40, P=0.042), and FI (PR = 4.09, 95% CI 1.21-13.81, P=0.023). In addition, POPDI (PR = 2.15, 95% CI 1.60-2.89, P<0.001), UDI (PR = 2.25, 95% CI 1.61-3.16, P<0.001), and PFDI (PR = 2.27, 95% CI 1.68-3.08, P<0.001) scores are also higher among adolescents where the baby is born by cesarean section. Conclusion: Adolescents present higher prevalence and symptoms of PFD; furthermore, cesarean delivery has a greater negative influence on the pelvic floor of adolescents when compared with young women. This reinforces the importance of PFD investigation among the adolescent population, mainly in developing countries which have high rates of adolescent pregnancy and cesarean section.
Palavras-chave
pelvic floor dysfunction, women's health, adolescent, puerperium
URI
https://observatorio.fm.usp.br/handle/OPI/29513
Referências
  1. Abreu LC, 2017, J HUM GROWTH DEV, V27, P258
  2. Adaji SE, 2014, EUR J OBSTET GYN R B, V174, P54, DOI 10.1016/j.ejogrb.2013.11.028
  3. Alperin M, 2016, AM J OBSTET GYNECOL, V215
  4. [Anonymous], 1986, World Health Organ Tech Rep Ser, V731, P1
  5. Association of Maternal and Child Health Programs, 2005, CONC FRAM AD HLTH CO
  6. Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025
  7. Bezerra I. M., 2016, J HUMAN GROWTH DEV, V26, P11, DOI 10.7322/JHGD.113709
  8. Brasil Ministerio da Saude, 2012, INF SAUD SIST INF NA
  9. Burgio KL, 2007, AM J GASTROENTEROL, V102, P1998, DOI 10.1111/j.1572-0241.2007.01364.x
  10. Buurman MBR, 2013, SCAND J CARING SCI, V27, P406, DOI 10.1111/j.1471-6712.2012.01044.x
  11. Chan SSC, 2013, INT UROGYNECOL J, V24, P1473, DOI 10.1007/s00192-012-2004-8
  12. de Araujo CC, 2018, INT UROGYNECOL J, V29, P639, DOI 10.1007/s00192-018-3609-3
  13. Delatorre MZ, 2015, J HUMAN GROWTH DEV, V25, P141
  14. Diez-Itza I, 2010, INT UROGYNECOL J, V21, P439, DOI 10.1007/s00192-009-1055-y
  15. Diniz CS, 2016, J HUM GROWTH DEV, V26, P33
  16. Durnea CM, 2014, INT UROGYNECOL J, V25, P1363, DOI 10.1007/s00192-014-2381-2
  17. Ege E, 2008, UROL INT, V80, P355, DOI 10.1159/000132691
  18. Arouca MAF, 2016, INT UROGYNECOL J, V27, P1097, DOI 10.1007/s00192-015-2938-8
  19. Fritel X, 2010, EUR J OBSTET GYN R B, V151, P14, DOI 10.1016/j.ejogrb.2010.02.041
  20. Gafni-Kane A, 2012, NEUROUROL URODYNAM, V31, P1252, DOI 10.1002/nau.22255
  21. Groen RS, 2015, INT J GYNECOL OBSTET, V129, P231, DOI 10.1016/j.ijgo.2014.12.008
  22. Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798
  23. Hebert-Beirne JM, 2017, J PEDIATR ADOL GYNEC, V30, P188, DOI 10.1016/j.jpag.2015.09.006
  24. Hojberg KE, 1999, BRIT J OBSTET GYNAEC, V106, P842, DOI 10.1111/j.1471-0528.1999.tb08407.x
  25. Hvidman L, 2002, INT UROGYNECOL J PEL, V13, P278, DOI 10.1007/s001920200061
  26. Kawakita T, 2016, J PEDIATR ADOL GYNEC, V29, P130, DOI 10.1016/j.jpag.2015.08.006
  27. Kepenekci I, 2011, DIS COLON RECTUM, V54, P85, DOI 10.1007/DCR.0b013e3181fd2356
  28. Koc O, 2011, INT UROGYNECOL J, V22, P1135, DOI 10.1007/s00192-011-1457-5
  29. Kongnyuy EJ, 2008, MATERN CHILD HLTH J, V12, P149, DOI 10.1007/s10995-007-0235-y
  30. MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x
  31. Moalli PA, 2003, OBSTET GYNECOL, V101, P869, DOI 10.1016/S0029-7844(03)00078-4
  32. Muganyizi PS, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-30
  33. Ng K, 2017, INT UROGYNECOL J, V28, P1393, DOI 10.1007/s00192-017-3281-z
  34. da Gama SGN, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00145513
  35. Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311
  36. Parden AM, 2016, FEMALE PELVIC MED RE, V22, P346, DOI 10.1097/SPV.0000000000000287
  37. Pereira LC, 2016, NEUROUROL URODYNAM, V35, P230, DOI 10.1002/nau.22703
  38. Rogers RG, 2014, BJOG-INT J OBSTET GY, V121, P1145, DOI 10.1111/1471-0528.12571
  39. Romano Mattea, 2010, J Prenat Med, V4, P22
  40. Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788
  41. Rortveit G, 2006, AM J OBSTET GYNECOL, V195, P433, DOI 10.1016/j.ajog.2006.01.023
  42. Rortveit Guri, 2014, Tidsskr Nor Laegeforen, V134, P1848, DOI 10.4045/tidsskr.13.0860
  43. Rostaminia G, 2016, FEMALE PELVIC MED RE, V22, P292, DOI 10.1097/SPV.0000000000000282
  44. Stewart CP, 2007, MATERN CHILD NUTR, V3, P174, DOI 10.1111/j.1740-8709.2007.00097.x
  45. Svanemyr J, 2015, J ADOLESCENT HEALTH, V56, pS7, DOI 10.1016/j.jadohealth.2014.09.011
  46. Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602
  47. Torvie AJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.024
  48. Valsky DV, 2016, J ULTRAS MED, V35, P709, DOI 10.7863/ultra.15.04032
  49. von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
  50. World Health Organization, 2004, AD PREGN ISS AD HLTH
  51. World Health Organization, 2015, WHORHR1502

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - LIM/58